Galectins and nanobodies on cancer cells
Galectins are pivotal player in cancer biology, particularly in triple-negative breast cancer (TNBC) where they promote immune evasion and tumor progression. This study shows the transcriptional signature of TNBC cells exposed to galectins with or without nanobodies as inhibitors at different time.